AKYA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Akoya Biosciences Inc (AKYA).


$113.50M Market Cap.

As of 03/17/2025 5:00 PM ET (MRY) • Disclaimer

AKYA Market Cap. (MRY)


AKYA Shares Outstanding (MRY)


AKYA Assets (MRY)


Total Assets

$125.00M

Total Liabilities

$117.41M

Total Investments

$23.26M

AKYA Income (MRY)


Revenue

$81.67M

Net Income

-$55.37M

Operating Expense

$95.12M

AKYA Cash Flow (MRY)


CF Operations

-$44.10M

CF Investing

-$24.05M

CF Financing

-$3.21M

AKYA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

AKYA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$125,005,000 (-30.69%)

$180,369,000 (2.46%)

$176,031,000 (-7.79%)

$190,907,000 (145.82%)

Assets Current

$76,732,000 (-37.00%)

$121,790,000 (8.55%)

$112,197,000 (-20.32%)

$140,814,000 (390.71%)

Assets Non-Current

$48,273,000 (-17.59%)

$58,579,000 (-8.23%)

$63,834,000 (27.43%)

$50,093,000 (2.31%)

Goodwill & Intangible Assets

$32,821,000 (-8.00%)

$35,674,000 (-6.88%)

$38,310,000 (-2.80%)

$39,412,000 (-3.82%)

Shareholders Equity

$7,595,000 (-85.88%)

$53,770,000 (-8.21%)

$58,581,000 (-51.73%)

$121,351,000 (337.82%)

Property Plant & Equipment Net

$12,983,000 (-37.15%)

$20,656,000 (-7.99%)

$22,449,000 (199.84%)

$7,487,000 (35.44%)

Cash & Equivalents

$12,465,000 (-85.13%)

$83,824,000 (12.47%)

$74,532,000 (-34.26%)

$113,381,000 (566.71%)

Accumulated Other Comprehensive Income

$7,000 (0%)

$0 (0%)

-$6,000 (0%)

$0 (0%)

Deferred Revenue

$9,617,000 (-2.67%)

$9,881,000 (17.73%)

$8,393,000 (44.36%)

$5,814,000 (19.83%)

Total Investments

$23,261,000 (0%)

$0 (0%)

$6,989,000 (0%)

$0 (0%)

Investments Current

$23,261,000 (0%)

$0 (0%)

$6,989,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$25,657,000 (36.69%)

$18,770,000 (13.28%)

$16,570,000 (43.31%)

$11,562,000 (100.83%)

Trade & Non-Trade Receivables

$13,779,000 (-18.92%)

$16,994,000 (74.67%)

$9,729,000 (3.02%)

$9,444,000 (45.97%)

Trade & Non-Trade Payables

$8,759,000 (-25.62%)

$11,776,000 (10.80%)

$10,628,000 (12.64%)

$9,435,000 (85.95%)

Accumulated Retained Earnings (Deficit)

-$285,436,000 (-24.06%)

-$230,071,000 (-37.98%)

-$166,748,000 (-73.50%)

-$96,107,000 (-83.83%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$129,000 (239.47%)

$38,000 (-56.32%)

$87,000 (234.62%)

$26,000 (-84.71%)

Total Debt

$84,146,000 (-1.82%)

$85,706,000 (13.09%)

$75,784,000 (130.07%)

$32,940,000 (-5.87%)

Debt Current

$3,283,000 (-4.79%)

$3,448,000 (-4.99%)

$3,629,000 (1234.19%)

$272,000 (-77.87%)

Debt Non-Current

$80,863,000 (-1.70%)

$82,258,000 (14.00%)

$72,155,000 (120.87%)

$32,668,000 (-3.25%)

Total Liabilities

$117,410,000 (-7.26%)

$126,599,000 (7.79%)

$117,450,000 (68.86%)

$69,556,000 (16.75%)

Liabilities Current

$29,444,000 (-16.70%)

$35,345,000 (-4.61%)

$37,055,000 (33.86%)

$27,682,000 (61.30%)

Liabilities Non-Current

$87,966,000 (-3.60%)

$91,254,000 (13.51%)

$80,395,000 (91.99%)

$41,874,000 (-1.28%)

AKYA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$81,672,000 (-15.48%)

$96,633,000 (29.09%)

$74,859,000 (36.31%)

$54,917,000 (29.39%)

Cost of Revenue

$33,794,000 (-16.20%)

$40,328,000 (28.15%)

$31,469,000 (52.03%)

$20,699,000 (25.18%)

Selling General & Administrative Expense

$69,317,000 (-15.86%)

$82,381,000 (3.42%)

$79,653,000 (56.13%)

$51,016,000 (112.73%)

Research & Development Expense

$19,745,000 (-9.79%)

$21,889,000 (-5.70%)

$23,211,000 (47.83%)

$15,701,000 (63.50%)

Operating Expenses

$95,120,000 (-15.33%)

$112,337,000 (2.50%)

$109,598,000 (53.41%)

$71,443,000 (91.02%)

Interest Expense

$10,429,000 (19.04%)

$8,761,000 (92.38%)

$4,554,000 (46.20%)

$3,115,000 (14.40%)

Income Tax Expense

$146,000 (265.00%)

$40,000 (-67.48%)

$123,000 (187.86%)

-$140,000 (-433.33%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$55,365,000 (12.57%)

-$63,323,000 (10.36%)

-$70,641,000 (-64.53%)

-$42,935,000 (-157.00%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$55,365,000 (12.57%)

-$63,323,000 (10.36%)

-$70,641,000 (-64.53%)

-$42,935,000 (-157.00%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$1,435,000 (-71.62%)

Net Income Common Stock

-$55,365,000 (12.57%)

-$63,323,000 (10.36%)

-$70,641,000 (-59.21%)

-$44,370,000 (-103.89%)

Weighted Average Shares

$49,418,535 (11.22%)

$44,434,570 (17.72%)

$37,746,915 (40.34%)

$26,896,976 (1034.62%)

Weighted Average Shares Diluted

$49,418,535 (11.22%)

$44,434,570 (17.72%)

$37,746,915 (40.34%)

$26,896,976 (1034.62%)

Earning Before Interest & Taxes (EBIT)

-$44,790,000 (17.85%)

-$54,522,000 (17.35%)

-$65,964,000 (-65.08%)

-$39,960,000 (-186.64%)

Gross Profit

$47,878,000 (-14.97%)

$56,305,000 (29.76%)

$43,390,000 (26.80%)

$34,218,000 (32.08%)

Operating Income

-$47,242,000 (15.69%)

-$56,032,000 (15.37%)

-$66,208,000 (-77.86%)

-$37,225,000 (-223.92%)

AKYA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$24,051,000 (-818.58%)

$3,347,000 (123.77%)

-$14,079,000 (-176.38%)

-$5,094,000 (-175.71%)

Net Cash Flow from Financing

-$3,205,000 (-105.64%)

$56,844,000 (97.88%)

$28,726,000 (-79.04%)

$137,035,000 (2397.90%)

Net Cash Flow from Operations

-$44,103,000 (13.35%)

-$50,899,000 (4.85%)

-$53,496,000 (-48.32%)

-$36,068,000 (-427.08%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$71,359,000 (-867.96%)

$9,292,000 (123.92%)

-$38,849,000 (-140.52%)

$95,873,000 (1685.01%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$21,595,000 (-408.50%)

$7,000,000 (203.34%)

-$6,774,000 (0%)

$0 (0%)

Capital Expenditure

-$2,456,000 (32.77%)

-$3,653,000 (49.99%)

-$7,305,000 (-43.40%)

-$5,094,000 (-54.60%)

Issuance (Repayment) of Debt Securities

-$1,022,000 (-109.70%)

$10,541,000 (-65.31%)

$30,389,000 (9537.58%)

-$322,000 (-104.03%)

Issuance (Purchase) of Equity Shares

$91,000 (-99.81%)

$48,313,000 (10708.28%)

$447,000 (-99.68%)

$138,947,000 (113790.98%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$9,306,000 (-10.84%)

$10,437,000 (40.47%)

$7,430,000 (83.96%)

$4,039,000 (746.75%)

Depreciation Amortization & Accretion

$7,654,000 (-13.90%)

$8,890,000 (24.35%)

$7,149,000 (49.19%)

$4,792,000 (25.61%)

AKYA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

58.60% (0.51%)

58.30% (0.52%)

58.00% (-6.90%)

62.30% (2.13%)

Profit Margin

-67.80% (-3.51%)

-65.50% (30.61%)

-94.40% (-16.83%)

-80.80% (-57.50%)

EBITDA Margin

-45.50% (3.60%)

-47.20% (39.95%)

-78.60% (-22.81%)

-64.00% (-167.78%)

Return on Average Equity (ROAE)

-290.60% (-163.70%)

-110.20% (-29.19%)

-85.30% (-66.60%)

-51.20% (-195.52%)

Return on Average Assets (ROAA)

-40.00% (-10.80%)

-36.10% (7.44%)

-39.00% (-46.62%)

-26.60% (-1.92%)

Return on Sales (ROS)

-54.80% (2.84%)

-56.40% (35.98%)

-88.10% (-21.02%)

-72.80% (-121.95%)

Return on Invested Capital (ROIC)

-30.70% (42.72%)

-53.60% (17.16%)

-64.70% (28.19%)

-90.10% (-114.52%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-2.04 (40.08%)

-3.41 (33.31%)

-5.12 (44.84%)

-9.28

Price to Sales Ratio (P/S)

1.39 (-38.24%)

2.24 (-53.50%)

4.83 (-35.64%)

7.5

Price to Book Ratio (P/B)

14.94 (235.52%)

4.45 (-28.17%)

6.2 (32.10%)

4.69

Debt to Equity Ratio (D/E)

15.46 (556.71%)

2.35 (17.41%)

2 (249.91%)

0.57 (149.06%)

Earnings Per Share (EPS)

-1.12 (21.68%)

-1.43 (23.53%)

-1.87 (-13.33%)

-1.65 (82.03%)

Sales Per Share (SPS)

1.65 (-24.00%)

2.17 (9.68%)

1.98 (-2.89%)

2.04 (-88.59%)

Free Cash Flow Per Share (FCFPS)

-0.94 (23.29%)

-1.23 (23.77%)

-1.61 (-5.29%)

-1.53 (64.23%)

Book Value Per Share (BVPS)

0.15 (-87.27%)

1.21 (-22.04%)

1.55 (-65.60%)

4.51 (120.96%)

Tangible Assets Book Value Per Share (TABVPS)

1.86 (-42.72%)

3.26 (-10.77%)

3.65 (-35.21%)

5.63 (-63.61%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (0.00%)

-4 (33.33%)

-6 (50.00%)

-12

Enterprise Value Over EBITDA (EV/EBITDA)

-4.99 (3.43%)

-5.16 (19.40%)

-6.41 (53.29%)

-13.72

Asset Turnover

0.59 (6.88%)

0.55 (33.33%)

0.41 (25.84%)

0.33 (-35.24%)

Current Ratio

2.61 (-24.38%)

3.45 (13.80%)

3.03 (-40.48%)

5.09 (204.25%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$46,559,000 (14.65%)

-$54,552,000 (10.28%)

-$60,801,000 (-47.71%)

-$41,162,000 (-306.02%)

Enterprise Value (EV)

$185,179,154 (-21.41%)

$235,639,724 (-37.47%)

$376,825,551 (-21.89%)

$482,405,770

Earnings Before Tax (EBT)

-$55,219,000 (12.74%)

-$63,283,000 (10.26%)

-$70,518,000 (-63.71%)

-$43,075,000 (-158.49%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$37,136,000 (18.62%)

-$45,632,000 (22.41%)

-$58,815,000 (-67.24%)

-$35,168,000 (-247.30%)

Invested Capital

$134,421,000 (20.85%)

$111,232,000 (9.14%)

$101,918,000 (134.99%)

$43,372,000 (15.63%)

Working Capital

$47,288,000 (-45.30%)

$86,445,000 (15.04%)

$75,142,000 (-33.58%)

$113,132,000 (880.86%)

Tangible Asset Value

$92,184,000 (-36.29%)

$144,695,000 (5.06%)

$137,721,000 (-9.09%)

$151,495,000 (312.97%)

Market Capitalization

$113,500,154 (-52.61%)

$239,491,724 (-34.07%)

$363,237,551 (-36.24%)

$569,651,770

Average Equity

$19,050,000 (-66.84%)

$57,442,000 (-30.60%)

$82,767,750 (-4.47%)

$86,641,000 (313.44%)

Average Assets

$138,368,250 (-21.02%)

$175,197,250 (-3.19%)

$180,969,750 (8.50%)

$166,785,250 (99.66%)

Invested Capital Average

$146,105,250 (43.64%)

$101,719,500 (-0.20%)

$101,927,000 (129.83%)

$44,348,750 (33.46%)

Shares

49,563,386 (0.99%)

49,076,173 (29.30%)

37,955,857 (2.01%)

37,207,823 (4.25%)